Texas developer envisions new Interlocken life-sciences campus
BROOMFIELD — Dallas developer Lincoln Property Co., alongside investor Federal Capital Partners, is planning a large new office, research and development, and light-manufacturing campus in Broomfield’s Interlocken business park, with the aim of attracting life-sciences industry tenants.
The project, known as CoRE – Colorado Research Exchange, will be built at 235 Interlocken Blvd. and is planned to total about 450,000 square feet spread across four buildings that will range from about 16,000 square feet for the development’s amenities center to nearly 200,000 square feet for the largest office building.
“Our purpose-built campus will include tenant spaces designed specifically to accommodate lab/life science or…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Enliven Therapeutics finished the third quarter with $292 million in cash, which, the company said,…
-
Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
Arca Biopharma has completed its merger with Oruka Therapeutics Inc.
